Rapid access for COVID-19 related research
Date of news: 30 March 2020
To support the investigation of the SARS-CoV-2 virus characteristics and the development of possible diagnostics, vaccine and treatments, the FELIX Laboratory offers rapid access to all its endstations for research related to SARS-CoV-2.
All projects will be evaluated on a case-to-case basis. Please use the template (docx, 292 kB) to describe the planned experiment and send your proposal as PDF file to email@example.com , referring to "Corona-related research" in the subject line.